GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 794 filers reported holding GLAXOSMITHKLINE PLC in Q4 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $21,000 | -4.5% | 491 | 0.0% | 0.01% | +9.1% |
| Q4 2021 | $22,000 | +15.8% | 491 | 0.0% | 0.01% | +10.0% |
| Q3 2021 | $19,000 | -5.0% | 491 | 0.0% | 0.01% | -9.1% |
| Q2 2021 | $20,000 | -70.6% | 491 | -73.9% | 0.01% | -71.1% |
| Q1 2021 | $68,000 | +54.5% | 1,882 | +58.0% | 0.04% | +22.6% |
| Q4 2020 | $44,000 | -42.9% | 1,191 | -41.9% | 0.03% | -55.7% |
| Q3 2020 | $77,000 | -18.1% | 2,051 | -11.5% | 0.07% | -27.1% |
| Q2 2020 | $94,000 | +2.2% | 2,318 | -4.6% | 0.10% | -17.9% |
| Q1 2020 | $92,000 | -29.2% | 2,430 | -19.9% | 0.12% | +37.6% |
| Q3 2019 | $130,000 | +4.8% | 3,035 | -2.4% | 0.08% | +2.4% |
| Q2 2019 | $124,000 | -26.2% | 3,110 | -22.7% | 0.08% | -35.7% |
| Q1 2019 | $168,000 | -22.9% | 4,021 | -25.9% | 0.13% | +22.9% |
| Q3 2018 | $218,000 | – | 5,430 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |